Rethinking Peritoneal Dialysis with Steady Concentration PD
Triomed's Carry Life UF system uses Steady Concentration Peritoneal Dialysis (SCPD) technology to address the limitations of conventional Peritoneal Dialysis (PD)
Why Carry Life UF?
-
Help Patients Stay on PD Longer
Dialysis is a life-saving treatment for people with kidney failure. PD is the preferred modality for home dialysis. However, as kidney disease progresses, conventional PD may no longer provide sufficient fluid removal, requiring patients to transition to hospital-based hemodialysis.
Developing innovative products, to improve PD treatment outcome and thereby help patients to stay on PD, is a core part of our mission.
-
Improved Quality of Life
Studies have shown that home dialysis improves patient health and quality of life. The clinical advantages of our systems enable PD patients to continue their treatment at home, empowering them to maintain their independence and preferred lifestyle.
Advantages with Carry Life UF
Improving Clinical Outcome
Optimized fluid management through increased water and sodium removal, while enhancing glucose efficiency.
Avoiding Glucose Peaks
Supports membrane preservation by reducing exposure to high dialysate glucose concentrations.
Compact and User-Friendly
Patients benefit from small portable devices, fewer PD bags, and reduced storage need.
Evidence-Based Innovation
Triomed is committed to evidence-based innovation. Our completed and ongoing clinical studies play a key role in guiding product development, ensuring that the Carry Life UF system meets the highest standards of safety and patient care.
The Carry Life UF system has been evaluated in several clinical studies, demonstrating safety, effectiveness, and potential to improve outcomes for patients on PD.
Scientific Publications
A Pilot Crossover Trial